Post-infarction myocardial remodelling: why does it happen?

G S Francis1, C Chu

  • 1Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.

European Heart Journal
|December 1, 1995
PubMed

Insights

Myocardial remodelling, a structural issue in heart failure, involves myocyte hypertrophy and other mechanisms. While the exact cause remains unclear, enlarged cardiac myocytes may contribute to heart failure symptoms.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Molecular Biology

Background:

  • Myocardial remodelling is a key process in heart failure, but its underlying mechanisms are not fully understood.
  • Current research focuses on understanding the structural and cellular changes that occur during cardiac remodelling.

Purpose of the Study:

  • To explore the multifaceted mechanisms contributing to myocardial remodelling.
  • To advance the understanding of heart failure as a structural problem.
  • To investigate the role of myocyte hypertrophy in cardiac remodelling.

Main Methods:

  • Review of existing scientific literature and clinical data.
  • Analysis of experimental models of left ventricular remodelling.
  • Examination of cellular and structural changes in cardiac myocytes.

Main Results:

  • Multiple mechanisms, including cell loss, myocyte slippage, collagen changes, and myocyte hypertrophy, are implicated in cardiac remodelling.
  • Direct evidence confirms myocyte enlargement in both experimental and clinical left ventricular remodelling.
  • Signal processing cascades are proposed as potential pathways leading to myocyte remodelling.

Conclusions:

  • Heart failure is increasingly viewed as a structural issue, with myocyte hypertrophy being a significant factor.
  • Enlarged cardiac myocytes may be structurally disadvantaged, contributing to heart failure.
  • Regression of myocardial remodelling, though rare, is observed experimentally and in some patients.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
643
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K